Search

Your search keyword '"Blood Buffy Coat"' showing total 213 results

Search Constraints

Start Over You searched for: Descriptor "Blood Buffy Coat" Remove constraint Descriptor: "Blood Buffy Coat" Topic humans Remove constraint Topic: humans
213 results on '"Blood Buffy Coat"'

Search Results

1. Heterogeneous GM-CSF signaling in macrophages is associated with control of Mycobacterium tuberculosis.

2. Cord blood buffy coat DNA methylation is comparable to whole cord blood methylation

Catalog

Books, media, physical & digital resources

3. Association of Mitochondrial DNA Copy Number With Cardiovascular Disease

4. miRNAs differentially expressed by next-generation sequencing in cord blood buffy coat samples of boys and girls

5. Divergent and dynamic activity of endogenous retroviruses in burn patients and their inflammatory potential

6. The platelet proteasome and immunoproteasome are stable in buffy‐coat derived platelet concentrates for up to 7 days

7. Comparison of capillary, venous and buffy coat blood samples in detecting Plasmodium species among malaria suspected patients attending at Hamusite health center. A cross-sectional study

8. Digital droplet polymerase chain reaction to monitor ultraviolet C treatment of single‐donor and buffy coat platelet units

9. Virion-incorporated PSGL-1 and CD43 inhibit both cell-free infection and transinfection of HIV-1 by preventing virus–cell binding

10. Platelet-Rich Fibrin Decreases the Inflammatory Response of Mesenchymal Cells

11. On the Use of Buffy or Whole Blood for Obtaining DNA of High Quality and Functionality: What Is the Best Option?

12. Blood donor‐derived buffy coat to produce platelets in vitro

13. Challenges in the Multivariate Analysis of Mass Cytometry Data: The Effect of Randomization

14. Human thioredoxin, a damage-associated molecular pattern and Malassezia-crossreactive autoallergen, modulates immune responses via the C-type lectin receptors Dectin-1 and Dectin-2

15. The comet assay for human biomonitoring: Effect of cryopreservation on DNA damage in different blood cell preparations

16. Influence of buffy coat–derived putative endothelial progenitor cells on tumor growth and neovascularization in oral squamous cell carcinoma xenografts

17. Evaluation of qPCR on blood and skin microbiopsies, peripheral blood buffy coat smear, and urine antigen ELISA for diagnosis and test of cure for visceral leishmaniasis in HIV-coinfected patients in India: a prospective cohort study

18. Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

19. The effect of cell isolation methods on the human transcriptome profiling and microbial transcripts of peripheral blood

20. Treatment and control strategies for COVID-19: Prospects and possibilities

21. Fast and Efficient Genome Editing of Human FOXP3

22. CD36 family members are TCR-independent ligands for CD1 antigen-presenting molecules

23. Cryopreservation of buffy coat derived platelets: Paired in vitro characterization using uncontrolled versus controlled freezing rate protocols

24. Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion

25. Downregulation of SERINC5 expression in buffy coats of HIV-1-infected patients with detectable or undetectable viral load

26. Diagnosis of the leukemic phase of ALK-positive anaplastic large cell lymphoma by immunohistochemistry on cell block prepared from peripheral blood buffy coat

27. Technical validation of a new microfluidic device for enrichment of CTCs from large volumes of blood by using buffy coats to mimic diagnostic leukapheresis products

28. Evaluating blood product quality post expiry to mitigate blood shortages during the COVID ‐19 pandemic in Canada

29. Relative Centrifugal Force (RCF;

30. Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature

31. Generation of a Human Allergic Mast Cell Phenotype from CD133

32. Pathogen reduction of double‐dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects

33. Buffy coat platelets coming to America: Are we ready?

34. PSGL-1 Restricts HIV-1 Infectivity by Blocking Virus Particle Attachment to Target Cells

35. Noncoding RNA MaIL1 is an integral component of the TLR4–TRIF pathway

36. Giardia lamblia Decreases NF-κB p65RelA Protein Levels and Modulates LPS-Induced Pro-Inflammatory Response in Macrophages

37. Risk-free point-of-care visceral leishmaniasis diagnostics: combining buffy coat microscopy and immunoassay in tertiary rural hospitals in Sudan

38. Epigenetic Alterations Are Associated With Gastric Emptying Disturbances in Diabetes Mellitus

39. Mucosal-associated invariant T-Cell (MAIT) activation is altered by chlorpyrifos- and glyphosate-treated commensal gut bacteria

40. An optimizedBRCA1/2next-generation sequencing for different clinical sample types

41. Characterization and internalization of small extracellular vesicles released by human primary macrophages derived from circulating monocytes

42. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation

43. Droplet digital PCR for absolute quantification of proviral load of human T-cell lymphotropic virus (HTLV) types 1 and 2

44. Quantification of total HIV-1 DNA in buffy coat cells, feasibility and potential added value for clinical follow-up of HIV-1 infected patients on ART

45. Optimized processing for pathogen inactivation of double‐dose buffy‐coat platelet concentrates: maintained in vitro quality over 7‐day storage

46. A comparison of different methods of red blood cell leukoreduction and additive solutions on the accumulation of neutrophil‐priming activity during storage

47. Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies

48. Molecular Evidence ofRickettsiain Human and Dog Blood in Bangkok

49. Secondary lymphoid organ fibroblastic reticular cells mediate trans-infection of HIV-1 via CD44-hyaluronan interactions

50. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation